Chapters

Transcript

Video

Can you summarize the key findings from the ARTISTRY-1 trial, with a special emphasis on signals that Part A of the trial provided regarding the potential efficacy and safety of nemvaleukin within the context of a small dose escalation study?


Created by

CMEducation Resources | iQ&A Cytokine Immunotherapy Intelligence Zone

Presenter

Ulka Vaishampayan, MBBS

Ulka Vaishampayan, MBBS

Professor of Internal MedicineDirector, Phase I ProgramRogel Cancer CenterUniversity of MichiganAnn Arbor, MI